1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Respiratory Device Market Trends
  5. > United States Respiratory Devices Market Outlook to 2021

United States Respiratory Devices Market Outlook to 2021

  • November 2015
  • -
  • GlobalData
  • -
  • 171 pages

United States Respiratory Devices Market Outlook to 2021

Summary

GlobalData’s new report, "United States Respiratory Devices Market Outlook to 2021", provides key market data on the United States Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, Positive Airway Pressure Devices, Reusable Resuscitators and Oxygen Conservers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Respiratory Devices market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, Positive Airway Pressure Devices, Reusable Resuscitators and Oxygen Conservers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Respiratory Devices market.
- Global corporate-level profiles of key companies operating within the United States Respiratory Devices market.
- Key players covered include Philips Respironics, Inc., Medtronic plc, ResMed Inc., GE Healthcare, Draegerwerk AG & Co. KGaA, Teleflex Incorporated, CareFusion Corporation and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States Respiratory Devices Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Respiratory Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Respiratory Devices Market, United States 13
3.1 Respiratory Devices Market, United States, Revenue ($m), 2007-2014 13
3.2 Respiratory Devices Market, United States, Revenue ($m), 2014-2021 15
3.2.1 Nebulizers Market, United States, Revenue ($m), by Segment, 2007-2014 17
3.2.2 Oxygen Concentrators Market, United States, Revenue ($m), by Segment, 2007-2014 19
3.2.3 Positive Airway Pressure Devices Market, United States, Revenue ($m), by Segment, 2007-2014 21
3.2.4 Ventilators Market, United States, Revenue ($m), by Segment, 2007-2014 23
3.2.5 Nebulizers Market, United States, Revenue ($m), by Segment, 2014-2021 25
3.2.6 Oxygen Concentrators Market, United States, Revenue ($m), by Segment, 2014-2021 27
3.2.7 Positive Airway Pressure Devices Market, United States, Revenue ($m), by Segment, 2014-2021 29
3.2.8 Ventilators Market, United States, Revenue ($m), by Segment, 2014-2021 31
3.3 Respiratory Devices Market, United States, Volume (Units), 2007-2014 33
3.4 Respiratory Devices Market, United States, Volume (Units), 2014-2021 35
3.4.1 Nebulizers Market, United States, Volume (Units), by Segment, 2007-2014 37
3.4.2 Oxygen Concentrators Market, United States, Volume (Units), by Segment, 2007-2014 39
3.4.3 Positive Airway Pressure Devices Market, United States, Volume (Units), by Segment, 2007-2014 41
3.4.4 Ventilators Market, United States, Volume (Units), by Segment, 2007-2014 43
3.4.5 Nebulizers Market, United States, Volume (Units), by Segment, 2014-2021 45
3.4.6 Oxygen Concentrators Market, United States, Volume (Units), by Segment, 2014-2021 47
3.4.7 Positive Airway Pressure Devices Market, United States, Volume (Units), by Segment, 2014-2021 49
3.4.8 Ventilators Market, United States, Volume (Units), by Segment, 2014-2021 51
3.5 Respiratory Devices Market, United States, Average Price ($), 2007-2021 53
3.6 Respiratory Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014 57
3.7 Respiratory Devices Market, United States, Company Share by Revenue ($m), 2014 58
4 Overview of Key Companies in United States, Respiratory Devices Market 60
4.1 Philips Respironics, Inc. 60
4.1.1 Company Overview 60
4.2 ResMed Inc. 60
4.2.1 Company Overview 60
4.3 Medtronic plc 60
4.3.1 Company Overview 60
4.4 GE Healthcare 61
4.4.1 Company Overview 61
4.5 Teleflex Incorporated 61
4.5.1 Company Overview 61
4.6 CareFusion Corporation 61
4.6.1 Company Overview 61
4.7 Draegerwerk AG and Co. KGaA 62
4.7.1 Company Overview 62
4.8 Smiths Medical 62
4.8.1 Company Overview 62
4.9 Fisher and Paykel Healthcare Corporation Limited 62
4.9.1 Company Overview 62
5 Respiratory Devices Market Pipeline Products 63
6 Financial Deals Landscape 65
6.1 Acquisition 65
6.1.1 Aerocare Acquires Matrix Medical 65
6.2 Asset Transactions 66
6.2.1 Becton, Dickinson Rumored to Sell Respiratory Devices Business 66
6.3 Debt Offerings 67
6.3.1 Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016 67
6.3.2 Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019 69
6.3.3 Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024 71
6.4 Equity Offerings 73
6.4.1 Teladoc Raises USD180.3 Million in IPO 73
6.4.2 Sangui Biotech to Raise USD5 Million in Private Placement of Shares 75
6.5 Partnerships 76
6.5.1 Capsule Tech Enters into Technology Integration Agreement with Masimo 76
6.5.2 University of Maryland Enters into Agreement with Breethe 77
6.6 Private Equity 78
6.6.1 Formation Capital, Safanad, Court Cavendish and Management Team at HC-One Acquire Meridian Healthcare Group 78
6.7 Venture Financing 79
6.7.1 Vapotherm Raises USD20 Million in Series C Financing 79
6.7.2 Spirometrix Raises USD8.6 Million in Series B Venture Financing 81
7 Recent Developments 82
7.1 Corporate Communications 82
7.1.1 Sep 03, 2015: Julian L. Cohen Joins Teladoc as General Manager and President of Teladoc Behavioral Health 82
7.1.2 Aug 06, 2015: R. Scott Greer Joins Inogen Board of Directors 82
7.1.3 Jun 30, 2015: ProVation MD Tapped by Olympus as Recommended EndoWorks Replacement 83
7.1.4 Jun 19, 2015: Mal Mixon to Retire from Invacare Board of Directors 84
7.1.5 May 14, 2015: Invacare Adds Two New Board Members 84
7.1.6 Apr 09, 2015: ALung Appoints David Motley to its Board of Directors 85
7.1.7 Jan 22, 2015: Invacare Names Matthew E. Monaghan President and Chief Executive Officer 85
7.1.8 Dec 22, 2014: Invacare Announces Interim Chairman of the Board of Directors 86
7.1.9 Dec 18, 2014: Pulmonx Names New Chief Executive Officer 87
7.1.10 Dec 18, 2014: Industry veteran Terrence W. Bunge joins MGC Diagnostics Board 88
7.1.11 Nov 17, 2014: Nanomix Appoints Dr. Tom Richards as Senior Advisor 88
7.1.12 Nov 14, 2014: Mal Mixon to Retire as Executive Chairman of Invacare at Year-End 88
7.2 Financial Announcements 89
7.2.1 Oct 22, 2015: Invacare Announces Financial Results for the Third Quarter and Nine Months of 2015 89
7.2.2 Oct 22, 2015: Utah Medical Products Reports Financial Performance for Third Quarter 2015 94
7.2.3 Sep 15, 2015: Electromed Reports Higher Fourth Quarter and Full Year Revenues and Profits 97
7.2.4 Sep 10, 2015: MGC Diagnostics Reports Fiscal 2015 Third Quarter Results 98
7.2.5 Aug 11, 2015: Inogen Announces Second Quarter 2015 Financial Results 100
7.2.6 Jul 23, 2015: Utah Medical Products Reports Financial Performance for Second Quarter 2015 102
7.2.7 Jul 23, 2015: Invacare Announces Financial Results for the Second Quarter and First Six Months of 2015 106
7.2.8 Jun 30, 2015: SANUWAVE Health Provides an Update on the dermaPACE Clinical Trial 110
7.2.9 Jun 02, 2015: MGC Diagnostics Reports Fiscal 2015 Second Quarter Results 111
7.2.10 May 12, 2015: Electromed Reports Higher Third Quarter Revenues and Profits 113
7.2.11 May 12, 2015: Inogen Announces First Quarter 2015 Financial Results 114
7.2.12 Apr 27, 2015: Inogen Announces Fourth Quarter and Full Year 2014 Financial Results 116
7.2.13 Apr 23, 2015: Invacare Announces Financial Results for the First Quarter of 2015 118
7.2.14 Apr 23, 2015: Utah Medical Products Reports Financial Performance for First Quarter 2015 121
7.2.15 Apr 16, 2015: Arch Therapeutics' AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study 124
7.2.16 Apr 07, 2015: Positive Clinical Data for iCAD's Xoft System to be Highlighted at American Brachytherapy Society Annual Meeting 125
7.2.17 Mar 30, 2015: BRILINTA receives US FDA approval for new administration option 127
7.2.18 Feb 10, 2015: Electromed Reports Higher Second Quarter Revenues and Profits 129
7.2.19 Feb 05, 2015: CareFusion Reports Second Quarter Fiscal 2015 Results 130
7.2.20 Feb 05, 2015: Invacare Announces Financial Results for the Quarter and Year Ended December 31, 2014 132
7.2.21 Jan 29, 2015: UTMD Reports Financial Performance for Fourth Quarter 137
7.2.22 Jan 29, 2015: Utah Medical Products Reports Financial Performance for Fourth Quarter and Year 2014 141
7.2.23 Jan 29, 2015: UTMD Reports Financial Performance for Fourth Quarter and Year 2014 145
7.2.24 Jan 07, 2015: MGC Diagnostics Reports Fiscal 2014 Fourth Quarter and Full Year Results 149
7.2.25 Nov 12, 2014: Electromed Reports Higher First Quarter Revenues and Profits 151
7.2.26 Nov 11, 2014: Inogen Releases Third Quarter 2014 Financial Results 152
7.2.27 Nov 06, 2014: CareFusion Reports First Quarter Fiscal 2015 Results 153
7.3 Legal And Regulatory 155
7.3.1 May 04, 2015: Federman and Sherwood Announces Filing of Securities Class Action Lawsuit Against Inogen 155
7.3.2 Mar 12, 2015: Bernstein Liebhard Announces That It Is Investigating Claims Against Inogen 155
7.3.3 Feb 18, 2015: OnCore Manufacturing Receives ISO13485 Certification and IPC J-STD-001 QML/ Qualified Manufacturer List at its Suzhou, China facility 155
7.3.4 Nov 25, 2014: Nanomix Receives ISO 13485:2003 Certification 156
7.4 Other Significant Developments 156
7.4.1 Oct 26, 2015: ZOLL Medical Strongly Supports Changes in AHA 2015 Guidelines 156
7.4.2 Jun 15, 2015: OxySure and Z-Medica Sign Distribution Agreement 157
7.4.3 May 17, 2015: NATEL and OnCore Renamed: NEO Tech 157
7.4.4 Feb 13, 2015: Invacare Declares Quarterly Dividend 158
7.4.5 Jan 16, 2015: Invacare Announces New Credit Agreement 158
7.4.6 Dec 23, 2014: ALung Releases its 2014 Year in Review Summary 159
7.4.7 Dec 09, 2014: CareFusion Receives Zenith Award For Respiratory Product Excellence 160
7.4.8 Dec 04, 2014: CSL Issues "Our Corporate Responsibility 2014" Report 161
7.4.9 Nov 21, 2014: Invacare Announces Quarterly Dividend 161
7.4.10 Nov 04, 2014: Utah Medical Products Increases Quarterly Dividend 162
7.5 Product News 162
7.5.1 Jun 25, 2015: Spacelabs Reinvents Medical Telemetry with Release of XTR 162
7.5.2 Apr 29, 2015: New study shows how babies' lives were saved by 3D printing 162
7.6 Strategy And Business Planning 164
7.6.1 Mar 25, 2015: Inogen Announces Full Operation of New Primary Manufacturing Facility 164
7.6.2 Mar 02, 2015: MES Opens New Warehouse in Houston 164
7.6.3 Feb 10, 2015: Codonics and CareFusion Expand Partnership 165
7.6.4 Dec 08, 2014: CareFusion And Kit Check To Help Providers Save Time And Improve Medication Safety From The Pharmacy To The OR 165
7.6.5 Dec 08, 2014: CareFusion, Medacist Partner To Reduce Drug Diversion 166
7.6.6 Dec 05, 2014: Inogen Expands Manufacturing Capacity to Accommodate Growth 167
8 Appendix 168
8.1 Research Methodology 169
8.1.1 Coverage 169
8.1.2 Secondary Research 169
8.1.3 Primary Research 169
8.1.4 Company Share Analysis 170
8.1.5 Distribution Share Analysis 170
8.2 GlobalData Consulting 170
8.3 Contact Us 170
8.4 Disclaimer 171

1.1 List of Tables
Table 1: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 2: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 16
Table 3: Nebulizers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 4: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 20
Table 5: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 22
Table 6: Ventilators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 24
Table 7: Nebulizers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 8: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Table 9: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Table 10: Ventilators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Table 11: Respiratory Devices Market, United States, Volume (Units), Historic, 2007-2014 34
Table 12: Respiratory Devices Market, United States, Volume (Units), Forecast, 2014-2021 36
Table 13: Nebulizers Market, United States, Volume (Units), Historic, 2007-2014 38
Table 14: Oxygen Concentrators Market, United States, Volume (Units), Historic, 2007-2014 40
Table 15: Positive Airway Pressure Devices Market, United States, Volume (Units), Historic, 2007-2014 42
Table 16: Ventilators Market, United States, Volume (Units), Historic, 2007-2014 44
Table 17: Nebulizers Market, United States, Volume (Units), Forecast, 2014-2021 46
Table 18: Oxygen Concentrators Market, United States, Volume (Units), Forecast, 2014-2021 48
Table 19: Positive Airway Pressure Devices Market, United States, Volume (Units), Forecast, 2014-2021 50
Table 20: Ventilators Market, United States, Volume (Units), Forecast, 2014-2021 52
Table 21: Respiratory Devices Market, United States, Average Price ($) Historic, 2007-2014 53
Table 22: Respiratory Devices Market, United States, Average Price ($), Forecast, 2014-2021 55
Table 23: Respiratory Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 57
Table 24: Respiratory Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2014 59
Table 25: Respiratory Devices Market Pipeline Products 63
Table 26: Aerocare Acquires Matrix Medical 65
Table 27: Becton, Dickinson Rumored to Sell Respiratory Devices Business 66
Table 28: Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016 67
Table 29: Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019 69
Table 30: Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024 71
Table 31: Teladoc Raises USD180.3 Million in IPO 73
Table 32: Sangui Biotech to Raise USD5 Million in Private Placement of Shares 75
Table 33: Capsule Tech Enters into Technology Integration Agreement with Masimo 76
Table 34: University of Maryland Enters into Agreement with Breethe 77
Table 35: Formation Capital, Safanad, Court Cavendish and Management Team at HC-One Acquire Meridian Healthcare Group 78
Table 36: Vapotherm Raises USD20 Million in Series C Financing 79
Table 37: Spirometrix Raises USD8.6 Million in Series B Venture Financing 81

1.2 List of Figures
Figure 1: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 2: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Figure 3: Nebulizers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 4: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 19
Figure 5: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 21
Figure 6: Ventilators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 23
Figure 7: Nebulizers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 8: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Figure 9: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Figure 10: Ventilators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Figure 11: Respiratory Devices Market, United States, Volume (Units), Historic, 2007-2014 33
Figure 12: Respiratory Devices Market, United States, Volume (Units), Forecast, 2014-2021 35
Figure 13: Nebulizers Market, United States, Volume (Units), Historic, 2007-2014 37
Figure 14: Oxygen Concentrators Market, United States, Volume (Units), Historic, 2007-2014 39
Figure 15: Positive Airway Pressure Devices Market, United States, Volume (Units), Historic, 2007-2014 41
Figure 16: Ventilators Market, United States, Volume (Units), Historic, 2007-2014 43
Figure 17: Nebulizers Market, United States, Volume (Units), Forecast, 2014-2021 45
Figure 18: Oxygen Concentrators Market, United States, Volume (Units), Forecast, 2014-2021 47
Figure 19: Positive Airway Pressure Devices Market, United States, Volume (Units), Forecast, 2014-2021 49
Figure 20: Ventilators Market, United States, Volume (Units), Forecast, 2014-2021 51
Figure 21: Respiratory Devices Market, United States, Company Share (%) 2014 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global Respiratory Devices Market Growth, Trends & Forecasts (2017 - 2022)

Global Respiratory Devices Market Growth, Trends & Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global respiratory devices market for the period 2016-2021 is expected to account for USD XX billion in 2021, growing at a CAGR of XX% from USD XX billion in 2016. Respiratory therapy in India is a ...

Respiratory Devices - Medical Devices Pipeline Assessment, 2016

Respiratory Devices - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Respiratory Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Respiratory Devices - Medical Devices Pipeline Assessment, 2016" provides an overview ...

Asia Pacific Respiratory Devices Market - Growth, Trends & Forecast (2017 - 2022)

Asia Pacific Respiratory Devices Market - Growth, Trends & Forecast (2017 - 2022)

  • $ 3850
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The major trend driving the Respiratory Devices market is the rising incidence of Chronic Obtrusive Pulmonary Disease population. APAC Respiratory Device market is currently estimated to be valued as $1.99 ...


Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

Respiratory Device
Medical Device

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.